SKVI — Skinvisible Income Statement
0.000.00%
Last trade - 00:00- $1.22m
- $6.95m
- $0.02m
- 52
- 30
- 47
- 38
Annual income statement for Skinvisible, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.276 | 0.663 | 0.279 | 0.02 | 0.02 |
| Cost of Revenue | |||||
| Gross Profit | 0.276 | 0.66 | 0.274 | 0.02 | 0.02 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.529 | 0.366 | 0.373 | 0.51 | -0.088 |
| Operating Profit | -0.254 | 0.298 | -0.094 | -0.49 | 0.108 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.45 | -1.07 | -1.22 | -2.38 | -0.566 |
| Net Income After Taxes | -1.45 | -1.07 | -1.22 | -2.38 | -0.566 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.45 | -1.07 | -1.22 | -2.38 | -0.566 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.45 | -1.07 | -1.22 | -2.38 | -0.566 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.322 | -0.26 | -0.302 | -0.525 | -0.25 |